CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-20 | Suria Hamza President, CEO | Sale | −19,208 | $35.75 | $687K | 74,122 |
| 2021-12-20 | Suria Hamza President, CEO | Sale | −5,522 | $36.40 | $201K | 68,600 |
| 2021-12-20 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −36,645 | 0 | ||
| 2021-11-26 | Faga Daniel Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2021-11-26 | Faga Daniel Director | Grant or award · Stock Option (Right to Buy) | +2,321 | 2,321 | ||
| 2021-11-15 | Lizzul Paul F. Chief Medical Officer | Grant or award | +964 | $22.03 | $21K | 964 |
| 2021-11-15 | Suria Hamza President, CEO | Grant or award | +964 | $22.03 | $21K | 68,600 |
| 2021-11-15 | LOUMEAU ERIC J COO, General Counsel | Grant or award | +523 | $22.03 | $12K | 523 |
| 2021-11-15 | MULROY DENNIS Chief Financial Officer | Grant or award | +964 | $22.03 | $21K | 964 |
| 2021-11-05 | Suria Hamza President, CEO | Exercise or conversion | +14,302 | $1.12 | $16K | 81,938 |
| 2021-11-05 | Suria Hamza President, CEO | Sale | −14,302 | $35.00 | $501K | 67,636 |
| 2021-11-05 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −14,302 | 0 | ||
| 2021-11-04 | Suria Hamza President, CEO | Exercise or conversion | +6,059 | $1.12 | $7K | 73,695 |
| 2021-11-04 | Suria Hamza President, CEO | Sale | −6,059 | $35.00 | $212K | 67,636 |
| 2021-11-04 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −6,059 | 14,302 | ||
| 2021-11-04 | LOUMEAU ERIC J COO, General Counsel | Exercise or conversion | +2,500 | $14.02 | $35K | 2,500 |
| 2021-11-04 | LOUMEAU ERIC J COO, General Counsel | Exercise or conversion | +2,500 | $20.16 | $50K | 5,000 |
| 2021-11-04 | LOUMEAU ERIC J COO, General Counsel | Sale | −5,000 | $35.00 | $175K | 0 |
| 2021-11-04 | LOUMEAU ERIC J COO, General Counsel | Exercise or conversion · Employee Stock Option (Right to Buy) | −2,500 | 85,500 | ||
| 2021-11-04 | LOUMEAU ERIC J COO, General Counsel | Exercise or conversion · Employee Stock Option (Right to Buy) | −2,500 | 7,500 |
Page 23 of 27 · 522 trades